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Participation of complement in the pathogenesis of a variety of immunologic
diseases has been established. Consequently, immune complexes and other
complement activating substances have been searched for in serum and other
body fluids ofrespective patients. Agnello, Winchester, and Kunkelhave utilized
isolated Clq for the detection of Clq-precipitable substances in pathological sera
and joint fluids (1, 2). In pursuing the approach ofthese authors itwas possible to
develop a procedure which is considerably more sensitive than the Clq precipitin
method.
This procedure is based on the inhibition by immune complexes of radiola-
beled Clq uptake to sensitized erythrocytes. The degree of inhibition can be
accurately quantitated. In the following we describe the development of the Clq
deviation test, its sensitivity with respect to different Clq reactants, and its
application to the exploration ofthe Clq-reactive material in pathological sera.
Materials and Methods
Clq.
￿
Highly purified Clq was isolated from fresh human serum as previously described (3). The
isolated protein was stored at aconcentration of 1 mg/ml in 0.1 M phosphate buffer, pH 7, at -70°C
until used.
Clq was labeled with
'251 according to the method of McConahey and Dixon (4). Specifically, 0.6
mCi of carrierfree
'251 (ICN Laboratories, Irvine, Calif.) and 10 pg of chloramine T were added to 1
mg of Clq. The mixture wasstirred for 10 min at 4°C andthereaction wasstoppedby addition of 10
jug of sodium metabisulfite. The labeled protein was dialyzed three times against 10 liters of 0.1 M
phosphate buffer, pH 7.2, for 36 h at 4°C and then subjected to ultracentrifugation in a Spinco no. 40
rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) at 35,000 rpm and4°C for 60 min.
Uptake of 1251 was approximately 50%, the specific radioactivity ranged between 0.25 and 0.4 ACi/
Ag protein. Bovine serum albumin (BSA)' at a concentration of 1 mg/ml was added before storage at
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-70°C. Thawed (1251) Clq was again centrifuged at 13,000 g for 5 min in a Beckman microfuge 152
before use.
Sensitized Sheep Erythrocytes. Sheep erythrocytes (E) were purchased from Colorado Serum
Co. Laboratories, Denver, Colo., rabbit antiserum to sheep erythrocytes (A) from Becton, Dickinson
and Co., Cockeysville, Md. Three types of sensitized sheep erythrocytes (EA) were prepared: cells
were sensitized either with unseparated antiserum, the IgGfraction, or the IgM-containing fraction of
theantiserum. In each instance the optimal amount of antibody wasdetermined as follows: cellswere
incubated at 37'C for 30 min with various dilutionsof the antibody source in isotonic Veronal buffer,
pH 7.5, containing 0.1% gelatin (GVB), washed, and tested forthe capacity to bind [125I]Clq as will
be described below. Forsensitization of E the dilution of antibody source was chosen which allowed
uptake of 40-60% of the radiolabeled Clq offered. The reaction volume was 450AL, the amount of
[125I]Clq 1 Ag, and the number of EA 4 x 108.
Clq-Reactive Materials.
￿
Soluble IgG aggregates were prepared by heating of solutions of Cohn
Fraction It (Lederle Laboratories, Pearl River, N.Y.), as previously described (5). The preparations
containing 30 mg protein per ml were stored at -70'C and after thawing, centrifuged before use at
2,000 rpm for 15 min in an International refrigerated centrifuge (International Scientific Instruments
Inc., Mountain View, Calif.). Only theupper two-thirds of thetube contentwasutilized.
Soluble immune complexes were prepared as follows. The IgG fraction of rabbit anti-BSA
antiserum was purified by precipitation with 50% saturated ammonium sulfate followed by DEAE
cellulose chromatography. TheIgG fraction was concentrated to 5mg protein perml, dialyzed against
phosphate-buffered saline, absorbed with EA, and centrifuged at 45,000 rpm for 60 minin a Spinco
ultracentrifuge using an SW 50 rotor. To 0.2 ml of rabbit IgG was added 0.2 ml of BSA solution
containing 10 fag to 10 mg/ml of protein. After I h at 37°C and 16 h at 4°C the precipitates were
removed by centrifugation, washed, and dissolved in 1 ml 0.1 M NaOH for protein determination.
The supernates were tested for their ability to bind Clq and to consume serum hemolytic activity.
The following microbial substances were used: (a) TCAextract of Escherichia coli 08 cell walls; (b)
TCAextract of E.coli 0136 cell walls; (c) TCAextract of E. coli 0115 cell walls; (d)staphylococcus G7
slime layer; (e) TCA extract of staphylococcus Copenhagen; (f) capsular carbohydrate ofpneumococ-
cus R3 type 83; (g) slime layer of staphylococcal phage type 80; (h) TCA extract of streptococcus
group L cell walls; (ti) lipopolysaccharide Salmonella typhosa 0901; and, G) Levan from Bacillus
subtilis. Substances (a) through (h) were kindly made available by Dr. Walter Karakawa,
Department of Microbiology, Pennsylvania State University, (i) was purchased from Difco
Laboratories, Detroit, Mich. and (j) was kindly provided by Dr. John Spizizen, Department of
Microbiology, Scripps Clinic and Research Foundation.
Calf thymus DNA was obtained from Calbiochem, San Diego, Calif. and was dissolved in saline
over a 48-h period at a concentration of 1 mg/ml. Denatured DNA was prepared from the above
solution by boilingfor 10 min. DNAsewas purchasedfrom Calbiochem andused at aconcentration of
0.2 mg/ml. 5mg of native DNAwastreated with 1 mgof DNAsefor3hat 20°C.
Buffers. Veronal buffer (VB) contained 8.383 g of NaCl, 0.3 g of Na barbital and 0.46 g of
barbituric acid perliter, andGVB wasprepared by addition of 1 gof gelatinto 9liters ofVB. Sucrose
Veronal buffer (SVB) contained 9.25% ultra-pure sucrose (Becton, Dickinson and Co., Cockeysville,
Md.), 0.025 M sodium barbital, 1.5x 10' M Ca++ and 5 x 10' M Mg++ . The pH was adjusted
to 7.2 with HCI, and the conductance to 3 mmho/cm with isotonic saline. SVB-EDTA contained
0.0125 M EDTA instead of Ca+' and Mg'' .
Serum Reagents.
￿
Normal human serum was obtained from healthy donors andstored at -70°C.
Sera from patients with Dengue feverwere collected as previously described (6) andstored at -70°C.
Before testing, the sera were centrifuged at 2,000 rpm for 30 min. .
Procedure of the C1q Deviation Test. The test consists of the following steps: (a) 50 Ail of
serum, 100 Al of saline, and 100 CAI of SVB are mixed in a plastic test tube, the pH being 7.2 and
the conductivity 9 mmho/cm; (b) the diluted serum sample is heated at 56°C for 30 min; (c) I t+g
of ['251]Clq contained in 10 ul solution is added to the sample and the mixture is held at 20°C for
15 min; (d) thereafter, 200 pl of sensitized sheep erythrocyte suspension is added which contains
4 x 10 8EA in SVB and incubation at 20°C is continued for15 min; (e) 200 jl of the reaction mixture
is layered on 150 ul of a 40% sucrose solution in 0.05 M sodium phosphate buffer, pH 7, contained
in a 400 1cl polyethylene microfuge tube (Beckman Instruments, Inc., Clinical Instrument Division,
Fullerton, Calif., cat. no. 314326) . Centrifugation is performed at 15,000 rpm (approximately 13,000A. T. SOBEL, V. A. BOKISCH, AND H. J. MULLER-EBERHARD
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g) for 5 min in a Beckman microfuge 152; (/) the microfuge tube is clamped with a hemostat 5 mm
above the tip of the tube; (g) the tip of the microfuge tube containing the pelleted cells is cut off
with a razor blade at the lower edge of the hemostat and is collected in a disposable tube. The upper
portion of the microfuge tube including its contents is addedto a second tube by releasingthe hemo-
stat; (h) the radioactivity in both tubes is measured; (i) the ["5I]Clq uptake by EA is calculated in
percent oftotal radioactivity recovered:
cpmin pellet
￿
X 100;
cpm in pellet + cpm in supernate
(j) to determine inhibition of [1251]Clq binding to EA by the test sample, uptake of Clq by EA in
presence of normal human serum is quantitated simultaneously. The percent inhibition of uptake
(orthepercentdeviation of Clqby the test sample) is calculated :
The steps are summarized in Table I.
% uptake in control - % uptake in test
x 100.
% uptake in control
TABLE I
Procedure of the C1q Deviation Test
(a) Mixing of 50 Ial serum + 100 Al saline + 100,ul SVB.
(b) Heatingofmixture at 56°Cfor30 min.
(c) Addition of 1 lAg
[1251] Clq.
(d) Firstincubation: 15 min, 20°C.
(e) Addition of4 x 108EA.
(f) Second incubation : 15 min, 20°C.
(g) Separation ofcells andfluidphase in 40%sucrose,
(h) Determination of distribution of radiolabel.
cpmpellet
(i) Calculation of uptake:
cpmpellet + cpmsupernate
(j)
￿
Calculation ofinhibition:
13,000 g, 5min.
x 100.
%uptake (control) - % uptake (test)
%uptake (control)
x 100.
Results
Binding of ["5I]Clq to Sensitized Sheep Erythrocytes . Fig. 1 shows the
extent ofuptake ofClq by EA as afunction of the conductance ofthe buffer used
for suspending the cells. Maximal uptake was obtained at 6-8 mmho/cm. For the
Clq deviation test a conductance of 7 mmho/cm was selected. Nonsensitized
cells (E) showed no uptake even at lowconductance.
Fig. 2 summarizes a comparative analysis of hemolysis and Clq uptake as a
function of the relative amounts and types of antibody used. It indicated that in
the case of IgM-type antibody, considerably more antibody is required for
optimal Clq uptake than for maximal hemolysis. In the case of IgG-type
antibody the requirements forboth reactions aresimilar. Since large quantities of
antibody cause hemagglutination, IgG-type anti-E was selected in preference to
IgM for the Clq deviation test. A sensitizing dose of antibody was chosen which
did not cause agglutination but allowed approximately 50% uptake under
standard conditions.
Fig. 3 shows a dose response curve for CIq uptake by EA. To avoid hemolysis142
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Binding of ["SI]Clq to EA as a function of the conductance of the buffer.
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￿
Quantitative comparison of Clquptake by EA and lysis of EA at different amounts of
IgG or IgM antibody to sheep erythrocytes. Optimalsensitization for Clquptake andhemoly-
sis is similar for IgG-type antibody, butdisparate for IgM type antibody.
the serum was either heated or fresh serum was used in the presence ofEDTA (5
x 10-3 M). Clq uptake was somewhat greater in heated than in EDTA serum.
Over a wide dose range, uptake was proportional to input. Forthe Clq deviation
test, an amount of 1 jig of Clq was chosen, because this amount proved a
sensitive indicator of small quantities of Clq-reactive material in the deviation
test.A. T. SOBEL, V. A. BOKISCH, AND H . J. MULLER-EBERHARD
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Clq uptake proceeds rapidly to 75% of the plateau value as depicted in Fig . 4.
On the basis of this kinetic experiment 10 min at 20°C were chosen as the
conditions for the Clq deviation test . Experiments not recorded here demon-
strated that the temperature optimum for Clq binding was 20°C .
Although serum Clq does not significantly inhibit uptake of radiolabeled Clq
(Fig . 3), addition to serum of unlabeled, isolated Clq produced a marked
inhibitory effect (Fig . 5) . This effect may indicate the specificity of ['z5I]Clq
binding .
Deuiation of [ 125I]Clq Binding to EA by Clq-Reactive Material Added to
Human Serum . Increasing quantities of soluble aggregates of human IgG were
added to various samples of a normal human serum and the mixtures were
incubated for 60 min at 37°C . The samples were then submitted to the Clq
FIG . 3 .
￿
['"I]Clq uptake by EA as a function of input . Uptake wasdetermined in presence of
heated and unheated (EDTA 5 x 10' M) serum . As control served E.
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FIG . 4 .
￿
Kinetic analysis of Clquptake by EA . Uptake is 75% of maximal value at 10 min.144
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deviation test, both after heating at 56°C for 30 min and without prior heat
treatment. Fig. 6 shows the sensitivity of the test in detecting IgG aggregates
added to normal serum. Reproducibly, 5 leg of aggregates/ml of serum could
clearly be detected, provided the test sample was heat-inactivated before testing.
It is suggested that heat treatment frees the aggregates from bound complement
100,
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60 Serum )56°,30 min)+Clq
Serum+Clq
--, Serum+Clq (56°,30 min)
2 4 10 20
Input of NOR-Rediolebeled Clq (16)
FIG. 5.
￿
Inhibition of uptake of radiolabeled Clq by nonradiolabeled Clq, and abolition of
inhibition by heat treatment. All samples contained 1 leg f..I]Clq and 5 x 10-3 M EDTA.
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FIG. 6.
￿
Deviation of ['251]Clq uptake by aggregated IgG. The indicated amounts of aggre-
gates were first incubated for 60 min at 37° C in fresh human serum. The samples were then
diluted 1:5 andonesetof sampleswasheated for30 min at 56° C in 5 x 10-'M EDTA,whereas
the other set received EDTA without heating. Detection of aggregates by the Clq deviation
test is more sensitive after heating of the test samples,A. T . SOBEL, V. A . BOKISCH, AND H. J. MULLER-EBERHARD
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proteins so that they become more reactive with Clq. The absolute amount of
aggregates detectable in the volume of serum selected for the test is 250 ng.
The value of Clq-reactive aggregates, however, is less than 100 ng because more
than half of the material consisted of unaggregated IgG as determined by
analytical ultracentrifugation.
To determine the reproducibility of the test, 10 different sera containing
Clq-reactive material were subjected to replicate examinations. The coefficient
of variation was 4.2%.
Fig. 7 demonstrates the capacity of the Clq deviation test to detect soluble
immune complexes. After removal of the precipitates of BSA and rabbit
anti-BSA, the supernates were tested for Clq-reactive material andfor hemolytic
complement consumption. The results of the Clq deviation test correlate with
those obtained by quantitation of hemolytic complement consumption.
6riu Serum OWN I/91
FIG. 7 . Deviation of [. ..I]Clq uptake by soluble immune complexes: correlation between
Clq-reactive complexes and complexes capable of activating complement. The antigen was
bovine serum albumin, the antiserum was of rabbit origin. After removal of the precipitates,
identical aliquots of all supernates were analyzed.
Various bacterial and phage products were tested for their ability to activate
complement. Using genetically C2-deficient serum and serum rendered deficient
in C3 proactivator by heating at 50°C for 20 min, it was determined whether
activation-of complement proceeded via the classical or the alternative pathway
or both. These results were compared with data obtained by analysis ofthe same
products with the Clq deviation test and the Clq precipitation-in-gel test (1).
The results are summarized in Table II and show that by and large substances
which activate the classical complement pathway are detected by the Clq
deviation test. They also reveal a good qualitative correlation between theresults
obtained with the latter test and the Clq precipitation-in-gel test. Highly
reactive bacterial products could readily be detected in the Clq deviation test at
concentrations of 20-30 Ag per ml of serum.
Clq reacts with single- and double-stranded DNA as has been demonstrated
by Agnello et al. (7). An examination of the sensitivity of the Clq deviation test
for the detection ofDNA in serum, showed that as little as 5,ug DNA/ml serum is
detectable, or 250 ng per test sample (50 gl). The dose response curves fornative
and denatured DNA and the abolition of the reaction by DNAse are demon-
strated in Fig. 8.146
￿
Clq DEVIATION TEST FOR DETECTION OF IMMUNE COMPLEXES
TABLE II
Detection of Bacterial and Phage Products in Serum by the Clq Deviation Test:
Comparison with Clq Precipitation-In-Gel Test and Correlation with Consumption of
Complement by the Classical or Alternative Pathway
* For detailed description see Materials and Methods.
$ 350 kg.
3.5 mg/ml.
11 700 kg/ml.
10
￿
25
DNA (pE/ml Serum)
FIG. 8.
￿
Deviation of ['25I]Clq uptake by native, denatured and DNAse treated DNA.
Application of the Clq Deviation Test to the Analysis of Pathological
Sera . 193 samples of serum from 43 patients with Dengue hemorrhagic fever
were analyzed. The results were correlated with the severity grade of the disease
in each case. As shown in Fig. 9 the least inhibition of [1ZSI]Clq uptake was seen
in group I which comprises patients with mild disease. The highest degree of
inhibition was associated with the occurrence of severe shock which is character-
istic for patients of group IV. When serial samples of individuals with disease
grade III and IV were tested, the most positive Clq deviation tests were observed
in serum obtained on the day of shock.
Products of:
Inhibition of
11251]Clq
uptake$
ClqPre-
cipitation §
Complement consumption
vial)
C1,4, 2 Properdin
E. coli 08 47 ++ ++ 0
E.coli0136 73 ++ ++ 0
E. coli 0115 37 ++ ++ 0
Staphylococcus G7 22 + ++ 0
Staphylococcus Copenhagen 0 0 + +++
Staphylococcus phage80 94 ++ + ++
Pneumococcus R3 18 ++ +++ 0
Streptococcus LC.W. 0 0 0 0
S. typhosa0901 12 0 0 ++
B. subtilis 0 0 0 +++A. T. SOBEL, V. A. BOKISCH, AND H. J. MULLER-EBERHARD
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FIG. 9.
￿
Application of the C1q deviation test to an analysis of serum samples from patients
with Dengue hemorrhagic fever . A total of 193samples were analyzed . The bars represent the
standard error of the mean .
Discussion
Several different approaches have been employed in search for a method
capable of detecting soluble immune complexes in serum and other body fluids .
These approaches included the utilization of hemolytic complement consump-
tion (S), Clq precipitation (1, 9), precipitation by monoclonal rheumatoid factor
(2), binding to cellular complement receptors (10), or Fc receptors (11), and
inhibition of phagocytosis (12) .
It was the purpose of this study to develop a simple, rapid, and economical test
with a high degree of sensitivity for complement reactive substances . Clq was
employed because, being the recognition protein of the classical complement
system, it has proved to be a sensitive detector of immune complexes and other
complement reactive materials . To achieve maximal sensitivity, binding of Clq
to immune complexes in serum was not measured directly . Instead, we
quantitated the interference of these complexes with Clq binding to sensitized
sheep erythrocytes (EA) . In a mixture ofEA, soluble immune complexes (AGAB)
and Clq, a proportion of Clq is deviated and bound by the complexes . This
amount, which is related to the quantity and reactivity of the complexes present,
is prevented from binding to EA . Compared to a complex-free reaction mixture,
EA-bound Clq is thereby diminished . The reactions of the control (a) and the test
(b) mixtures may be represented as (a) EA + Clq - EAClq + Clq ; (b) EA +
AGAB + Clq --" EAClq + AGABClq + Clq. Clq was detected by a radiolabel
after separation of cells and fluid phase . Although the introduction of ...I by the
chloramine T method may abolish Clq hemolytic activity, it does not impair the
immunoglobulin-binding activity of the protein (13) . Separation of cell-bound
and fluid phase Clq was accomplished by layering the mixture on a high density
sucrose solution which was followed by brief centrifugation . After centrifugation,
complex-bound and free Clq (top) are separated from EAClq (bottom) by a zone
which was completely devoid of radioactivity . Quantitation of radioactivity in148
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both fractions allows accurate determination of Clq deviation from EA by
Clq-reactive substances. For optimal sensitivity, the amount of hemolysin used
to prepare EA is critical. Since individual batches of hemolysin differ in Clq
reactivity, the optimal sensitizing dose with respect to Clq binding has to be
determined for each batch. This dose may differ considerably from the optimal
sensitizing dose used for complement-dependent hemolysis.
The sensitivity of the Clq deviation test is significantly greater than that of
othertests utilizing Clq for the detection of soluble immune complexes. Whereas
the Clq precipitation-in-gel test and the radiolabeled Clq precipitation test
detect y-globulin aggregates at minimum concentrations of 100 'Ug/ml and 50
,ug/ml, respectively, Clq deviation allows the detection of 5 Ag/ml. The smallest
absolute amount of aggregates detectable by Clq deviation is approximately 250
ng. It is also noteworthy that the entire test can be completed within 1-2 h, and
that 50 Al of test serum is sufficient for one determination. The use of
glutaraldehyde-fixed EA in the test is presently under investigation. Given the
stability of such modified indicator cells and the known stability of radiolabeled
Clq on storage over longer periods of time, the routine performance of the test
may become feasible in clinical laboratories. It is probable that the sensitivity of
the test can be further enhanced by perfecting the methodology.
The Clq deviation test is similar in sensitivity to the test employing cultured
lymphoblastoid cells for the binding of immune complexes (10). However, the
two reactions are governed by different principles. Lymphoblastoid cells bind
immune complexes present in serum primarily by virtue of their complement
receptors for C3b and C3d which react with the complex-bound complement
proteins . The reaction of the complexes in serum with complement thus is a
prerequisite for their detectability by lymphoblastoid cells. In contrast, Clq
reacts directly with the immunoglobulin of immune complexesprovided that it is
of the IgG or IgM type. Complement bound to the immune complexes may
therefore reduce their reactivity with Clq. Apparently, heating at 56°C reverses
binding of complement to these complexes and renders them accessible to Clq.
The reactivity of IgG aggregates previously incubated in fresh serum was
increased after heat treatment ofthe mixture (Fig. 6). In order to minimize or to
prevent the aggregation of serum -y-globulin during heat treatment, the test
serum was diluted fivefold before heating. There was no evidence that this
treatment resulted in an increase of Clq-reactive material. However, the
possibility exists that Clq reactants which are relatively thermolabile, may be
inactivated.
In the test developed by Nydegger et al. (9) it is necessary to separate free Clq
from Clq which is bound to soluble immune complexes. This is accomplished by
differential precipitation ofthe latter at a critical concentration ofpolyethylene
glycol. Separation oftwo solubleforms ofClq is not required in the Clq deviation
test. Instead, free and complex-bound Clq are removed together and separated
from solid-phase Clq (EAClq) by the simple and highly accurate technical
procedure described. Mere washing of EAClq before quantitation of cell-bound
Clq was not feasible because of the reversibility of Clq binding. Washing also
renders quantitation of fluid-phase Clq inaccurate or impossible.
Clq is known not only to react with aggregated -1-globulin and immuneA. T. SOBEL, V. A. BOKISCH, AND H. J. MVLLER-EBERHARD
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complexes, but also with certain endotoxins (14) and with DNA (15).
These non-Ig substances are also recognized in the Clq deviation test, which
must be borne in mind in regard to the evaluation of a positive result.
A limited and preliminary application of the test to clinical material has been
performed. Patients with Dengue hemorrhagic fever may be categorized accord-
ing to severity of disease in grades I-IV. Sera from patients with disease grade IV
exhibited the highestdegree of Clq deviation and those from patients with grade
I the lowest . Serial serum samples of individual grade IV patients gave the
highest value for Clq deviation at the dayof shock when the serum concentration
of C3 and other complement proteins was lowest compared to earlier or later
serum samples. The nature of the Clq-reactive material in Dengue serum has not
been determined. However, the partially purified material was able to activate
complement in normal human serum. For the isolation of Clq-reactive material
from Dengue and from other pathological sera, the deviation test should prove a
useful assay for tracing the material through consecutive preparative steps.
Summary
This report describes a new, rapid, sensitive, and quantitative method for the
detection of immune complexes, endotoxins, and other complement activating
materials in patient's sera utilizing the ability of these substances to react with
isolated Clq. The procedure is based on the inhibition of radiolabeled Clq
binding to sensitized sheep erythrocytes by CIq-reactive substances in pathologi-
cal sera. The Clq deviation test may be performed on 50 Al of serum, using 1
gg of radiolabeled Clq per sample. The procedure may be completed in 1.5-2
h, it is capable of detecting 5 lug of aggregated human IgG per ml of serum, and
its coefficient of variation is 4.2%. Application of the test to the study of 193
sera from 43 patients with Dengue hemorrhagic fever showed a positive correla-
tion between degree of Clq deviation and severity of disease.
We wish to thank Ms.Rhonda Mayo forherskillful technicalassistance.
Received for publication 20 March 1975.
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